Oracle Corp (ORCL) Insider Sells 29,225 Shares

2 min readBy Investing Point

Naomi O. Seligman, an insider at Oracle Corp (ORCL), sold 29,225 shares of the company stock at a price of $288.91 per share, resulting in a total transaction value of $8.44 million. This sale occurred on September 25, 2025. Following this transaction, Seligman retains 29,225 shares of Oracle Corp.

Oracle Corp operates in the technology sector, providing products and services that address various aspects of corporate information technology environments. The company is headquartered in Austin, Texas, and employs 162,000 full-time staff. It operates through three main businesses: cloud and license, hardware, and services. The cloud and license segment focuses on the sale and delivery of enterprise applications and infrastructure technologies, while the hardware business offers infrastructure technologies to support diverse IT environments. The services segment aids customers and partners in maximizing their investments in Oracle's offerings.

As of November 20, 2025, Oracle has a market capitalisation of $642.9 billion, a price-to-earnings ratio of 51.68, and an earnings per share figure of 4.32. The company's dividend yield stands at 88.7%. Upcoming earnings announcements include estimates of $2.05 per share on revenue of $19.4 billion for June 9, 2026, and $1.75 per share on revenue of $17.2 billion for March 9, 2026.

Insider transactions are reported to the SEC, providing transparency into the actions of company executives. While Seligman’s sale is a single data point, investors are encouraged to consider broader patterns of insider activity across multiple insiders and time periods when evaluating these signals.

This brief was generated from structured financial data and reviewed by the Investing Point editorial team. It is for informational purposes only and does not constitute investment advice. Market data provided by Finnhub.

Related Stocks

More in this Category

Insider Trades

Explore more insider trades or view detailed analysis for ORCL stock.